Imago BioSciences, Inc. Common stock
IMGO
IMGO was delisted on the 10th of January, 2023.
52 hedge funds and large institutions have $607M invested in Imago BioSciences, Inc. Common stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 1 closing their positions.
1,300% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 1
283% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 6
33% more funds holding
Funds holding: 39 → 52 (+13)
28% more capital invested
Capital invested by funds: $473M → $607M (+$134M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.3M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$9.92M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$9.51M |
| 4 |
BlackRock
New York
|
+$4.92M |
| 5 |
Millennium Management
New York
|
+$3.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.15M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.63M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.77M |
| 4 |
PA
Perceptive Advisors
New York
|
-$2.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$412K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $18K | – | – | – |
|
52
Daiwa Securities Group
Tokyo,
Japan
| $2K | +$2.27K | +98 | New |
|
|
PA
53
Perceptive Advisors
New York
| – | -$2.5M | -125,000 | Closed |
|
IMGO Hedge Fund Activity: Q4 2021 in Review
52 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q4 2021, worth a combined $607M — up 28% from $473M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IMGO positions and 1 closed out — a net gain of 13 holders — while 23 added to existing stakes and 6 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $18.3M. The largest seller was Vanguard Group, cutting an estimated $6.15M.
- 52 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q4 2021, up from 39 in Q3 2021.
- Funds reported $607M of Imago BioSciences, Inc. Common stock stock for Q4 2021, up 28% quarter-over-quarter.
- 14 funds opened new Imago BioSciences, Inc. Common stock positions in Q4 2021 and 1 closed out, a net change of +13 holders.
- The largest Imago BioSciences, Inc. Common stock buyer in Q4 2021 was Fidelity Investments, an estimated $18.3M added.
- The largest Imago BioSciences, Inc. Common stock seller in Q4 2021 was Vanguard Group, an estimated $6.15M sold.
Based on aggregated 13F filings for Q4 2021.